| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 3,308,000 | 3,751,000 | 3,875,000 | 3,764,000 | | Cost of Revenue | 477,000 | 558,000 | 677,000 | 515,000 | | | Gross Profit | 2,831,000 | 3,193,000 | 3,198,000 | 3,249,000 | | | Operating Expenses | | Research Development | 633,000 | 798,000 | 729,000 | 809,000 | | Selling General and Administrative | 798,000 | 1,491,000 | 900,000 | 894,000 | | Non Recurring | 5,000 | (306,000) | 12,000 | 294,000 | | Others | 74,000 | 73,000 | 74,000 | 73,000 | | | | Total Operating Expenses | 1,510,000 | 2,056,000 | 1,715,000 | 2,070,000 | | | | Operating Income or Loss | 1,321,000 | 1,137,000 | 1,483,000 | 1,179,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (89,000) | 333,000 | (12,000) | 9,000 | | Earnings Before Interest And Taxes | 1,232,000 | 1,470,000 | 1,471,000 | 1,188,000 | | Interest Expense |
-
| 316,000 |
-
|
-
| | Income Before Tax | 1,232,000 | 1,154,000 | 1,471,000 | 1,188,000 | | Income Tax Expense | 213,000 | 193,000 | 313,000 | 247,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,019,000 | 961,000 | 1,158,000 | 941,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,019,000 | 961,000 | 1,158,000 | 941,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,019,000 | $961,000 | $1,158,000 | $941,000 |
|
1.73% Nasdaq 
Income Statement
